IOL CHEMICALS & PHARM. | NATCO PHARMA | IOL CHEMICALS & PHARM./ NATCO PHARMA |
|||
---|---|---|---|---|---|
P/E (TTM) | x | 13.7 | 14.3 | 95.3% | View Chart |
P/BV | x | 1.6 | 3.8 | 41.4% | View Chart |
Dividend Yield | % | 1.0 | 0.5 | 186.3% |
IOL CHEMICALS & PHARM. NATCO PHARMA |
EQUITY SHARE DATA | |||||
---|---|---|---|---|---|
IOL CHEMICALS & PHARM. Mar-23 |
NATCO PHARMA Mar-23 |
IOL CHEMICALS & PHARM./ NATCO PHARMA |
5-Yr Chart Click to enlarge
|
||
High | Rs | 537 | 847 | 63.4% | |
Low | Rs | 272 | 502 | 54.2% | |
Sales per share (Unadj.) | Rs | 377.6 | 148.4 | 254.5% | |
Earnings per share (Unadj.) | Rs | 23.7 | 39.2 | 60.5% | |
Cash flow per share (Unadj.) | Rs | 31.6 | 48.2 | 65.5% | |
Dividends per share (Unadj.) | Rs | 4.00 | 5.50 | 72.7% | |
Avg Dividend yield | % | 1.0 | 0.8 | 121.3% | |
Book value per share (Unadj.) | Rs | 256.8 | 267.1 | 96.1% | |
Shares outstanding (eoy) | m | 58.71 | 182.47 | 32.2% | |
Bonus / Rights / Conversions | 0 | 0 | - | ||
Price / Sales ratio | x | 1.1 | 4.5 | 23.6% | |
Avg P/E ratio | x | 17.1 | 17.2 | 99.2% | |
P/CF ratio (eoy) | x | 12.8 | 14.0 | 91.5% | |
Price / Book Value ratio | x | 1.6 | 2.5 | 62.4% | |
Dividend payout | % | 16.9 | 14.0 | 120.3% | |
Avg Mkt Cap | Rs m | 23,743 | 123,049 | 19.3% | |
No. of employees | `000 | NA | NA | - | |
Total wages/salary | Rs m | 1,682 | 4,867 | 34.6% | |
Avg. sales/employee | Rs Th | 0 | 0 | - | |
Avg. wages/employee | Rs Th | 0 | 0 | - | |
Avg. net profit/employee | Rs Th | 0 | 0 | - |
INCOME DATA | |||||
---|---|---|---|---|---|
Net Sales | Rs m | 22,171 | 27,071 | 81.9% | |
Other income | Rs m | 256 | 1,285 | 19.9% | |
Total revenues | Rs m | 22,427 | 28,356 | 79.1% | |
Gross profit | Rs m | 2,257 | 9,117 | 24.8% | |
Depreciation | Rs m | 462 | 1,638 | 28.2% | |
Interest | Rs m | 165 | 145 | 113.6% | |
Profit before tax | Rs m | 1,887 | 8,619 | 21.9% | |
Minority Interest | Rs m | 0 | 0 | - | |
Prior Period Items | Rs m | 0 | 0 | - | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | - | |
Tax | Rs m | 495 | 1,466 | 33.8% | |
Profit after tax | Rs m | 1,391 | 7,153 | 19.5% | |
Gross profit margin | % | 10.2 | 33.7 | 30.2% | |
Effective tax rate | % | 26.2 | 17.0 | 154.3% | |
Net profit margin | % | 6.3 | 26.4 | 23.8% |
BALANCE SHEET DATA | |||||
---|---|---|---|---|---|
Current assets | Rs m | 9,667 | 30,003 | 32.2% | |
Current liabilities | Rs m | 5,025 | 6,831 | 73.6% | |
Net working cap to sales | % | 20.9 | 85.6 | 24.5% | |
Current ratio | x | 1.9 | 4.4 | 43.8% | |
Inventory Days | Days | 43 | 63 | 68.2% | |
Debtors Days | Days | 8 | 115 | 7.2% | |
Net fixed assets | Rs m | 11,017 | 26,571 | 41.5% | |
Share capital | Rs m | 587 | 365 | 160.8% | |
"Free" reserves | Rs m | 14,490 | 48,373 | 30.0% | |
Net worth | Rs m | 15,077 | 48,738 | 30.9% | |
Long term debt | Rs m | 0 | 0 | - | |
Total assets | Rs m | 20,684 | 56,574 | 36.6% | |
Interest coverage | x | 12.5 | 60.4 | 20.6% | |
Debt to equity ratio | x | 0 | 0 | - | |
Sales to assets ratio | x | 1.1 | 0.5 | 224.0% | |
Return on assets | % | 7.5 | 12.9 | 58.3% | |
Return on equity | % | 9.2 | 14.7 | 62.9% | |
Return on capital | % | 13.6 | 18.0 | 75.7% | |
Exports to sales | % | 26.7 | 0 | - | |
Imports to sales | % | 0 | 10.2 | 0.0% | |
Exports (fob) | Rs m | 5,930 | NA | - | |
Imports (cif) | Rs m | NA | 2,772 | 0.0% | |
Fx inflow | Rs m | 5,930 | 17,256 | 34.4% | |
Fx outflow | Rs m | 6,052 | 2,772 | 218.3% | |
Net fx | Rs m | -122 | 14,484 | -0.8% |
CASH FLOW | |||||
---|---|---|---|---|---|
From Operations | Rs m | 1,223 | 8,491 | 14.4% | |
From Investments | Rs m | -1,200 | -4,771 | 25.2% | |
From Financial Activity | Rs m | -41 | -3,630 | 1.1% | |
Net Cashflow | Rs m | -18 | 208 | -8.8% |
Indian Promoters | % | 48.2 | 49.7 | 96.9% | |
Foreign collaborators | % | 0.0 | 0.0 | - | |
Indian inst/Mut Fund | % | 1.7 | 25.8 | 6.6% | |
FIIs | % | 1.4 | 16.1 | 8.7% | |
ADR/GDR | % | 0.0 | 0.0 | - | |
Free float | % | 51.8 | 50.3 | 103.0% | |
Shareholders | 130,003 | 228,467 | 56.9% | ||
Pledged promoter(s) holding | % | 0.0 | 0.0 | - |
Compare IOL CHEMICALS & PHARM. With: DIVIS LABORATORIES CIPLA SUN PHARMA DR. REDDYS LAB ZYDUS LIFESCIENCES
No comparison is complete without understanding how the stock prices have performed over a period of time.
Here's a brief comparison:
Period | IOL CHEMICALS & PHARM. | Natco Pharma | S&P BSE HEALTHCARE |
---|---|---|---|
1-Day | -0.56% | 2.26% | 0.97% |
1-Month | 5.64% | 6.68% | 2.08% |
1-Year | -1.14% | 79.37% | 55.37% |
3-Year CAGR | -12.91% | 4.07% | 15.04% |
5-Year CAGR | 16.34% | 13.74% | 19.56% |
* Compound Annual Growth Rate
Here are more details on the IOL CHEMICALS & PHARM. share price and the Natco Pharma share price.
Moving on to shareholding structures...
The promoters of IOL CHEMICALS & PHARM. hold a 48.2% stake in the company. In case of Natco Pharma the stake stands at 49.7%.
To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of IOL CHEMICALS & PHARM. and the shareholding pattern of Natco Pharma.
Finally, a word on dividends...
In the most recent financial year, IOL CHEMICALS & PHARM. paid a dividend of Rs 4.0 per share. This amounted to a Dividend Payout ratio of 16.9%.
Natco Pharma paid Rs 5.5, and its dividend payout ratio stood at 14.0%.
You may visit here to review the dividend history of IOL CHEMICALS & PHARM., and the dividend history of Natco Pharma.
For a sector overview, read our pharmaceuticals sector report.
Indian share markets continued the momentum as the session progressed and ended the higher.